substance p has been researched along with Leucocythaemia in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, Y; Chen, Q; Fu, C; Ge, C; Huang, F; Huang, H; Kang, J; Liu, L; Pearson, RB; Shi, Y; Sun, Y; Wang, X; Wu, H; Yang, T; Zhang, T; Zhou, H | 1 |
Konwerska, A; Miskowiak, B; Nowicki, M; Ostalska-Nowicka, D | 1 |
Kondraciuk, B; Miskowiak, B; Nowicki, M; Ostalska-Nowicka, D | 1 |
Goetzl, EJ; Payan, DG | 1 |
Munekata, E; Takenouchi, T | 1 |
Chernov, T; Goetzl, EJ; Payan, DG; Renold, F | 1 |
1 review(s) available for substance p and Leucocythaemia
Article | Year |
---|---|
The significance of substance P in physiological and malignant haematopoiesis.
Topics: Antineoplastic Agents; Bone Marrow; Cell Transformation, Neoplastic; Hematopoiesis; Humans; Leukemia; Neoplasm Metastasis; Neoplasm Proteins; Neoplasms; Substance P; Tachykinins | 2007 |
5 other study(ies) available for substance p and Leucocythaemia
Article | Year |
---|---|
Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload.
Topics: Adult; Aged; Animals; Apoptosis; Calcium; Cell Line, Tumor; Female; Humans; Inflammation; Leukemia; Leukemia, Myeloid, Acute; Male; Mice; Mice, Inbred ICR; Middle Aged; Mitochondria; Neurokinin-1 Receptor Antagonists; Oxidative Stress; Receptors, Neurokinin-1; Signal Transduction; Substance P | 2019 |
The predicting role of substance P in the neoplastic transformation of the hypoplastic bone marrow.
Topics: Adolescent; B-Lymphocytes; Bone Marrow Diseases; Bone Marrow Examination; Cell Transformation, Neoplastic; Child; Child, Preschool; Disease Progression; Humans; Immunoenzyme Techniques; Immunophenotyping; In Situ Hybridization; Ki-67 Antigen; Leukemia; Leukemia, Myeloid, Acute; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Substance P | 2006 |
Inhibition by somatostatin of the release of mediators from human basophils and rat leukemic basophils.
Topics: Animals; Antibodies, Anti-Idiotypic; Basophils; Dose-Response Relationship, Immunologic; Histamine Release; Humans; Immunoglobulin E; Immunosuppressive Agents; Leukemia; Peptides; Rats; Somatostatin; SRS-A; Substance P | 1984 |
Trophic effects of substance P and beta-amyloid peptide on dibutyryl cyclic AMP-differentiated human leukemic (HL-60) cells.
Topics: Amino Acid Sequence; Amyloid beta-Peptides; Bucladesine; Calcium; Cell Differentiation; Cell Survival; Culture Media, Serum-Free; Humans; L-Lactate Dehydrogenase; Leukemia; Molecular Sequence Data; Peptide Fragments; Substance P; Superoxides; Tumor Cells, Cultured | 1995 |
Neuropeptide regulation of the expression of immediate hypersensitivity.
Topics: Basophils; Endorphins; Humans; Hypersensitivity, Immediate; Leukemia; Mast Cells; Nerve Tissue Proteins; Neurotensin; Neurotransmitter Agents; Somatostatin; Substance P; Vasoactive Intestinal Peptide | 1985 |